REGENEREX PHARMA, INC. Quarterly Depreciation in USD from Q2 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Regenerex Pharma, Inc. quarterly/annual Depreciation history and growth rate from Q2 2018 to Q2 2024.
  • Regenerex Pharma, Inc. Depreciation for the quarter ending June 30, 2024 was $1.14K, a 37.7% increase year-over-year.
  • Regenerex Pharma, Inc. annual Depreciation for 2023 was $4.28K, a 25.1% increase from 2022.
  • Regenerex Pharma, Inc. annual Depreciation for 2022 was $3.42K, a 3.09% decline from 2021.
  • Regenerex Pharma, Inc. annual Depreciation for 2021 was $3.53K, a 24.3% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $1.14K +$313 +37.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q2 2023 $831 -$240 -22.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q2 2022 $1.07K +$574 +115% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q2 2021 $497 -$1.33K -72.8% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q2 2020 $1.83K +$400 +28% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q2 2019 $1.43K +$99.00 +7.44% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q2 2018 $1.33K Apr 1, 2018 Jun 30, 2018 10-Q 2019-07-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.